- The European Commission's approval is based on the CHMP positive opinion
- Label update comes in response to new biomarker data obtained from the OPUS study
Wall Street could be in for a rocky week in the wake of the Republicans' failure to repeal and replace Obamacare as promised.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.